{"id":5281,"date":"2017-06-06T23:26:23","date_gmt":"2017-06-06T21:26:23","guid":{"rendered":"http:\/\/tyr\/miloamerge\/produits\/aliments-complementaires\/anti-ageing\/"},"modified":"2025-02-13T11:58:54","modified_gmt":"2025-02-13T10:58:54","slug":"anti-ageing","status":"publish","type":"post","link":"https:\/\/miloa.eu\/en\/products\/supplements\/anti-ageing\/","title":{"rendered":"Anti-Ageing<\/span>"},"content":{"rendered":"
\n
\n

USE<\/h3>\n

\n\t\t\tThe nutritional components of Miloa Anti-Ageing\u2122 work together to optimise the well-being of pets that are showing signs of ageing, sustain psychological and cognitive acquisition, and support the memory and physical abilities.\t<\/p>\n

\n\t\t\tBlackcurrant, bilberry, co-enzyme Q10 and vitamin E are powerful antioxidants that neutralise free radicals.\n\t\t<\/p>\n

<\/br>\n<\/div>\n<\/div>\n

\n
\n
\n
\n

ADDITIVE<\/h3>\n
    \n
  • Vitamins: Vitamin E10,430 UI\/kg<\/span><\/li>\n<\/ul><\/div>\n<\/p><\/div>\n
    \n
    \n

    COMPOSITION<\/h3>\n
      \n
    • Fish meal <\/span><\/li>\n
    • Ribes nigrum (blackcurrant)<\/span><\/li>\n
    • Panax ginseng (ginseng) <\/span><\/li>\n
    • Vaccinium myrtillus (bilberry)<\/span><\/li>\n
    • Panax quinquefolius (american ginseng)<\/span><\/li>\n
    • Ginkgo biloba (ginkgo) <\/span><\/li>\n
    • Melissa officinalis (lemon balm) <\/span><\/li>\n
    • Inactive yeast rich in co-enzyme Q10<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n
      \n

      INSTRUCTIONS FOR USE<\/h3>\n
        \n
      • For dogs and cats < 10 kg:1\/2 tab\/d<\/span><\/li>\n
      • Dogs between 10 and 20 kg: 1 tab\/d<\/span><\/li>\n
      • Dogs between 20 and 30 kg:2 tabs\/d<\/span><\/li>\n
      • Dogs > 30 kg:3 tabs\/d<\/span><\/li>\n<\/ul>\n

        The above quantities can be doubled in the first two weeks. The period of use of Miloa Anti-Ageing\u2122 can vary according to your pet\u2019s needs. The tablets are extremely palatable. Most cats and dogs will swallow them without fuss, but they can also be crushed and mixed with food.<\/p>\n<\/p><\/div>\n<\/div>\n

        <\/p>\n

        \n
        \n

        STORAGE<\/h3>\n

        Store in a cool (< 25 \u00b0C) and dry place in original packaging. Keep away from the sun light. Close tightly after opening. Keep out of reach of children. Best before 24 months after the date of manufacture. Batch number and date of manufacture: see packaging.<\/p>\n<\/div>\n

        \n

        PRESENTATION<\/h3>\n

        Box with 60<\/span> palatable tablets.
        Each tablet weighing 2 g<\/span>.
        Net weight: 120 g<\/span>.<\/p>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

        When our pets age, their central nervous system displays a loss of neurons, brain atrophy and a calcification of the meninges (Head, 2001 ; Roudebush & al, 2005). Most of the atrophy occurs in the cortex. There is a correlation between cortical atrophy and cognitive problems (Rofina & al, 2006) in both humans and dogs (Du & al, 2005 ; Ezekiel & al, 2004). Deposits of platelets of amyloid-beta peptides are also observed. These deposits increase with age and are linked to the severity of the cognitive deficiency (Colle & al, 2000). These amyloid-beta platelets are neurotoxic and compromise normal neuron function. There are also a great many vascular and peri-vascular changes. These can restrict blood flow and the supply of essential nutrients (Gerlach & al, 1994 ; Araujo & al, 2002). As the brain ages, it is less able to fight oxidative stress, a cause of neuron malfunction (Kiaipattanasakul & al, 1997 ; Head & al, 2002). All these tissue changes explain the decline of cognitive function, disorientation, memory loss, disturbance of the day\/night cycles and withdrawal.<\/p>\n","protected":false},"author":1,"featured_media":15599,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[173],"tags":[],"class_list":["post-5281","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-supplements"],"acf":[],"_links":{"self":[{"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/posts\/5281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/comments?post=5281"}],"version-history":[{"count":0,"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/posts\/5281\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/media\/15599"}],"wp:attachment":[{"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/media?parent=5281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/categories?post=5281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/miloa.eu\/en\/wp-json\/wp\/v2\/tags?post=5281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}